Proteomic Profiling of Chemotherapy Responses in FOLFOX-Resistant Colorectal Cancer Cells
International Journal of Molecular Sciences · 08.06.2023 · 24 (12) · 9899
DOI: 10.3390/ijms24129899 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.06.2023. Verfasst von Shing-Yau Tam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Kowloon, Hong Kong. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Kong Polytechnic University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemoresistance mechanisms of colorectal cancer remain largely elusive. We aim to compare the difference of chemotherapy responses between FOLFOX-resistant and wild-type colorectal cancer cells by proteomic profiling to suggest novel treatment targets. FOLFOX-resistant colorectal cancer cells DLD1-R and HCT116-R were developed by chronic exposure to progressive FOLFOX doses. Proteomic profiling of FOLFOX-resistant and wild-type cells under FOLFOX exposure were conducted by mass-spectrometry-based protein-analysis technology. Verification of selected KEGG pathways was conducted by Western blot. DLD1-R had significantly higher FOLFOX-chemoresistance (10.81 times) than its wild-type counterpart. A total of 309 and 90 differentially expressed proteins were identified in DLD1-R and HCT116-R, respectively. In terms of gene ontology molecular function, RNA binding and cadherin binding ranked first for DLD1 and HCT116 groups, respectively. For gene set enrichment analysis, ribosome pathway and DNA replication were significantly up-regulated and down-regulated in DLD1-R, respectively. The most significantly up-regulated pathway in HCT116-R was regulation of the actin cytoskeleton. Up-regulations in the ribosome pathway (DLD1-R) and actin cytoskeleton (HCT116-R) were verified by Western blot. There were several significantly altered signaling pathways in FOLFOX-resistant colorectal cancer cells under FOLFOX with notable up-regulations in the ribosomal process and actin cytoskeleton.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Technology and Informatics, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Kowloon, Hong Kong.
ORCID-Profile: Shing-Yau Tam, Ju-Yu Chen, Helen Ka-Wai Law
Förderung
- Hong Kong Polytechnic University
Zitieren
APA
Tam, S. Y., Islam Khan, M. Z., Chen, J. Y., Yip, J. H., Yan, H. Y., Tam, T. Y., & Law, H. K. (2023). Proteomic Profiling of Chemotherapy Responses in FOLFOX-Resistant Colorectal Cancer Cells. International Journal of Molecular Sciences, 24(12), 9899. https://doi.org/10.3390/ijms24129899
Vancouver
Tam SY, Islam Khan MZ, Chen JY, Yip JH, Yan HY, Tam TY, et al. Proteomic Profiling of Chemotherapy Responses in FOLFOX-Resistant Colorectal Cancer Cells. International Journal of Molecular Sciences. 2023;24(12):9899. doi:10.3390/ijms24129899
BibTeX
@article{Tam2023,
author = {Tam, Shing-Yau and Islam Khan, Md Zahirul and Chen, Ju-Yu and Yip, Jerica Hiu-Yui and Yan, Hong-Yiu and Tam, Tsz-Yan and Law, Helen Ka-Wai},
title = {Proteomic Profiling of Chemotherapy Responses in FOLFOX-Resistant Colorectal Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {12},
pages = {9899},
doi = {10.3390/ijms24129899}
}
EUVIMED